Earnings call transcript: H2O America Q2 2025 sees EPS growth, strategic Texas expansion

H2O America reported robust Q2 2025 results, with adjusted EPS increasing 14% year-over-year to $0.75 and revenue rising 13% to $10.9 million, both exceeding expectations. The company reaffirmed its 2025 adjusted diluted EPS guidance of $2.90 to $3.00 and its 5-7% long-term earnings growth rate through 2029. A key strategic driver is the acquisition of QuadVest in Texas, which is expected to significantly expand H2O America's market presence and become accretive from 2028 after initial dilution in 2026-2027, complemented by substantial infrastructure investments and favorable regulatory developments across its operating states.

Analysis

H2O America (formerly SJW Group) reported a strong second quarter for 2025, demonstrating successful execution of its growth strategy. The company posted a 14% year-over-year increase in adjusted EPS to $0.75 on a 13% rise in revenue to $10.9 million, beating expectations. Critically, management reaffirmed its 2025 adjusted EPS guidance of $2.90 to $3.00 and its long-term 5-7% EPS growth target through 2029. The primary catalyst for future growth is the strategic acquisition of QuadVest, which will position H2O America as the second-largest investor-owned water utility in Texas. While this transaction is expected to be dilutive to earnings in 2026 and 2027, it is projected to become accretive in 2028 and meaningfully enhance long-term growth. This M&A activity is supported by a robust $473 million capital investment plan for 2025 and significant regulatory victories, including a new mechanism in Connecticut for faster recovery of PFAS-related investments and favorable legislation in Texas that allows for a future test year in rate cases, reducing regulatory lag and de-risking future returns.

Key Decisions for Investors

• Investors should recognize the dual growth drivers from the $473 million capital investment plan and the transformative QuadVest acquisition, which are supported by significant regulatory de-risking in key states.
• It is crucial to monitor the QuadVest acquisition's progress, particularly the fair market value appraisal, and to model for the expected EPS dilution in 2026-2027 before the deal becomes accretive in 2028.
• The recent positive regulatory changes in Connecticut (PFAS cost recovery) and Texas (future test year) represent a fundamental enhancement to the company's risk profile, potentially justifying a valuation premium relative to peers.
• With the stock trading near its 52-week high, prospective investors should carefully evaluate the entry point, while the company's strong strategic execution provides a solid rationale for current shareholders to maintain their positions.